Summary: Researchers have mapped the molecular landscapes of autism spectrum disorder (ASD) to understand how hundreds of different genetic mutations shape the developing brain. Using single-nucleus multi-omics sequencing across more than 250 samples, the team tracked gene expression, chromatin accessibility, and other epigenetic signals in specific brain cell types at multiple developmental stages.
Although the genetic mutations studied are highly diverse, they converge on the same brain cell types and developmental pathways during early brain formation. The shared effects primarily appear as transient delays in cellular maturation and neural connectivity rather than permanent structural defects. In preclinical models many of these differences began to normalize about two weeks after birth.
The study also revealed clear sex-specific molecular responses: female models often showed distinct and sometimes larger changes than males. These findings argue against a single, universal drug for ASD and instead point to stage-, sex-, and trajectory-specific strategies for early intervention.
Key Facts
- Convergent pathways: Diverse autism-linked genetic mutations affect the same brain cell types and molecular processes in early development.
- Transient delays: The main disruptions are temporary delays in cell maturation and synaptic connectivity rather than irreversible defects.
- Sex differences: Female models show different molecular responses to high-risk ASD mutations compared with males, indicating sex-specific biology.
- Single-nucleus multi-omics: The study analyzed over 250 individual nuclei, capturing DNA, RNA activity, and epigenetic marks at single-cell resolution.
- Therapeutic window: Shared developmental differences diminish around two weeks after birth in mouse models, suggesting a critical early window for targeted therapies.
Source: ISTA
Background
Hundreds of genes have been associated with autism, yet the cellular and molecular mechanisms by which they alter brain development remain incompletely understood. This new study, led by Gaia Novarino at the Institute of Science and Technology Austria (ISTA) and published in Nature, used state-of-the-art single-nucleus multi-omics to compare multiple monogenic mouse models of ASD across developmental time, sexes, and brain regions.
Autism spectrum disorder is genetically complex: some cases result from rare, high-impact mutations in single genes, while others reflect combinations of many factors. This genetic heterogeneity has raised the question of whether different causes produce fundamentally distinct brain changes or whether they converge on common developmental processes.
To answer that question, the research team profiled 251 samples from 11 monogenic mouse models of ASD across three developmental stages, both sexes, and two brain regions. They applied single-nucleus multi-omics sequencing to capture multiple molecular layers in individual nuclei: the genomic context, transcriptional activity (RNA), and epigenetic regulation.
What the team found
Despite the genetic heterogeneity, the mutations converged on perturbations of the radial glial cell lineage, a key progenitor lineage in cortical development. Importantly, these alterations reflected a transient developmental delay rather than a lasting change in cell fate, resolving by later postnatal stages in the mouse models.
At the molecular level, the largest transcriptional differences appeared in neurons at early postnatal stages. These differences included downregulation of synaptic and ion channel-related genes, patterns consistent with delayed maturation or homeostatic adaptation. Network analyses revealed that molecular convergence across models was most pronounced within specific developmental stages and diminished by postnatal day 14.
Electrophysiological measurements supported the molecular findings: mutants generally showed altered neuronal excitability and synaptic properties, with model-specific details layered on top of a shared pattern. The study also observed sex-specific gene expression changes, with female mice often displaying larger effect sizes than male mice.
Implications for therapy and research
These results suggest that diverse genetic causes of autism disrupt a common, stage-specific network of developmental processes rather than producing wholly separate diseases. Because many disruptions are transient and resolve by early postnatal stages, there appears to be a critical, time-sensitive window when targeted interventions might be most effective.
Crucially, the pronounced sex differences in molecular response indicate that future therapeutic strategies will need to be tailored by biological sex as well as by developmental stage and individual genetic trajectory. In other words, effective treatments are more likely to be precision approaches that consider when and in whom they are applied.
Key Questions Answered
A: No. While each mutation leaves a distinct molecular signature, this research shows that diverse autism-linked mutations ultimately converge on the same brain cell types and developmental pathways, disrupting a shared core network during early development.
A: The main effect is a temporary delay in cell maturation and synaptic connectivity rather than permanent structural defects. In mouse models many molecular differences began to fade by two weeks after birth, highlighting developmental plasticity and a limited window for intervention.
A: Because ASD biology varies by developmental stage, genetic background, and biological sex. The study found female brains often respond differently to high-risk mutations than male brains, indicating that therapies should be tailored to the patient’s sex, age, and genetic-molecular profile.
Editorial Notes
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full.
- Additional context was added by the editorial staff.
About this research
Author: Andreas Rothe
Source: ISTA
Contact: Andreas Rothe – ISTA
Image: Image credit: Neuroscience News
Original research (open access):
“Cortical development dynamics across autism spectrum disorder mouse models” by Lena A. Schwarz et al., Nature. DOI: 10.1038/s41586-026-10679-1
Abstract (condensed)
This study profiled 251 samples from 11 monogenic mouse models of ASD using single-nucleus multi-omics across three developmental stages, both sexes, and two brain regions. Despite genetic heterogeneity, ASD-linked mutations converged on perturbations of the radial glial lineage and transient delays in neuronal maturation. Molecular convergence was stage-specific and decreased by postnatal day 14. Electrophysiology supported altered excitability and synaptic properties, and sex-specific gene expression differences were prominent, especially in females. Together, these results offer a comprehensive view of developmental cellular and molecular dynamics across ASD models and point to time- and sex-sensitive opportunities for intervention.